• Dextrose (D-glucose): Precision Control of Cellular Metaboli

  2026-05-19

  Explore how Dextrose (D-glucose) enables highly controlled modeling of glucose metabolism in tumor microenvironment research. This article uniquely reveals practical strategies for dissecting metabolic competition and immunometabolic adaptation using APExBIO’s high-purity D-glucose.

• Annexin V-Cy5/DAPI Apoptosis Kit: Unrivaled Precision in Mit

  2026-05-19

  Explore the Annexin V-Cy5/DAPI Apoptosis Kit as a powerful apoptosis detection kit, with a unique focus on mitochondrial apoptosis and mechanistic assay optimization. This article delivers actionable insight for researchers seeking deeper differentiation of cell death pathways.

• Sodium Ascorbate: Protocols and Troubleshooting for Cancer R

  2026-05-18

  Sodium Ascorbate, a mineral salt of ascorbic acid, offers superior bioavailability and a unique ability to induce intracellular ROS for targeted necrotic tumor cell death. This guide delivers actionable experimental workflows, optimization strategies, and troubleshooting tips to elevate glioblastoma and broader cancer research.

• Ciprofloxacin Sensitizes Cancer Cells to Ferroptosis via Mit

  2026-05-18

  This study reveals that ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells by promoting mitochondrial Zn²⁺ accumulation through the STING1–CAV2 pathway. The findings demonstrate context-dependent modulation of ferroptosis by ciprofloxacin and highlight new therapeutic opportunities for regulating cell death in oncology.

• A Drug-Sensitized Yeast Platform for mTOR Inhibitor Discover

  2026-05-17

  This study introduces a yeast-based drug-sensitized system that dramatically increases the sensitivity for detecting mTOR pathway inhibitors, enabling efficient identification of new candidate compounds. Its methodological advances offer researchers a rapid and cost-effective tool for early-stage screening of TOR inhibitors, with clear applicability for aging and metabolic disease research.

• Fluorescein TSA Fluorescence System Kit: Unrivaled Signal Am

  2026-05-16

  The Fluorescein TSA Fluorescence System Kit empowers researchers to map low-abundance proteins and nucleic acids with unprecedented clarity, outperforming conventional fluorescence detection in immunohistochemistry, immunocytochemistry, and in situ hybridization. Leveraging robust tyramide signal amplification, this APExBIO solution unlocks new dimensions in spatial mapping and biomarker discovery.

• nor-Binaltorphimine Dihydrochloride: Elevating KOR Circuit R

  2026-05-15

  This thought-leadership article frames the mechanistic and translational importance of nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist. We synthesize the latest circuit-level findings, benchmark protocol insights, and provide strategic recommendations for researchers aiming to advance opioid receptor signaling research and pain modulation studies.

• Dual Luciferase Reporter Gene System: Protocols & Use Cases

  2026-05-15

  The Dual Luciferase Reporter Gene System empowers researchers to unravel transcriptional regulation with high sensitivity and reliability. This article delivers actionable protocols, workflow enhancements, and troubleshooting strategies for maximizing assay performance in mammalian cell cultures.

• ROS-Degradable Lipid Nanoparticles for Tumor-Selective mRNA

  2026-05-14

  This study introduces a combinatorial library of biodegradable lipid nanoparticles, featuring a thioketal moiety, that enables selective mRNA delivery and gene expression in tumor cells by exploiting elevated reactive oxygen species (ROS) levels. The findings demonstrate improved efficacy for mutant RAS blockade, with implications for targeted mRNA therapeutics and advanced biotherapeutic development.

• Applied Workflows Using Anti-ROR1 Antibody (Zilovertamab)

  2026-05-14

  Deploy Anti-ROR1 Antibody (Zilovertamab) for precise Wnt5a-induced ROR1 signaling inhibition in functional, kinetic, and FACS assays. This guide details experimental best practices and troubleshooting informed by recent mechanistic insights into antibody-driven cancer research.

• VX-765: Precision Caspase-1 Inhibition in Inflammation Resea

  2026-05-13

  VX-765, a potent and selective caspase-1 inhibitor, empowers researchers to dissect IL-1β/IL-18-driven inflammation and pyroptosis with exceptional specificity. Discover how its proven efficacy, practical protocol tips, and robust troubleshooting strategies make it indispensable for studies in rheumatoid arthritis, infectious disease, and beyond.

• ExoU, Lipid Metabolism, and Cell Death in P. aeruginosa Infe

  2026-05-13

  This study elucidates the mechanisms by which the ExoU effector from Pseudomonas aeruginosa induces host cell death, focusing on lipidomic changes and the relative roles of apoptosis, necroptosis, and ferroptosis. The work's multifaceted approach clarifies that ExoU-driven cytotoxicity is closely linked to membrane hydrolysis and transient ferroptotic responses rather than classical apoptosis.

• AZD0156: Precision ATM Kinase Inhibition for Translational O

  2026-05-12

  Explore how AZD0156, a potent ATM kinase inhibitor, is redefining cancer therapy research by enabling precision DNA damage response modulation. This in-depth analysis unpacks mechanistic, assay, and translational advances beyond existing guides.

• EPI-001: Transforming AR-Driven Cancer Research Strategies

  2026-05-12

  Explore how EPI-001, a pioneering androgen receptor N-terminal domain inhibitor from APExBIO, is reshaping translational cancer research. This article integrates mechanistic insight, experimental validation, and strategic guidance for targeting AR and its splice variant ARv7, especially in castration-resistant prostate cancer and triple-negative breast cancer. By uniting evidence from recent clinical studies with applied workflows, we outline how EPI-001 empowers researchers to overcome longstanding challenges in AR signaling pathway inhibition and disease modeling.

• Novobiocin Sodium Blocks Membrane and Vacuole Biogenesis in

  2026-05-11

  This study demonstrates that Novobiocin Sodium, an aminocoumarin antibiotic, inhibits both plasma membrane synthesis and vacuole formation in Enterococcus faecalis protoplasts by disrupting DNA replication. These findings deliver mechanistic clarity on the coupling between DNA replication and organelle biogenesis in Gram-positive bacteria, informing new approaches for cell cycle and antibiotic resistance research.

500 records 14/34 page Previous Next First page 上5页 1112131415 下5页 Last page